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213 Positive expiratory pressure values in infants: A pilot study
R. Stewart1, P. Anderson1. 1Royal Hospital for Sick Children, Glasgow, United
Kingdom
Background: Positive expiratory pressure (PEP) therapy forms the basis of airway
clearance in cystic ﬁbrosis (CF). National guidelines suggest that resistance for
PEP should be between 10 and 20 cmH20. However, there are no guidelines for
infants. Based on the fact that infant airways are more compliant than adults, it was
hypothesised that PEP pressures reached in infants would be less than the literature
suggests but with similar outcomes.
Aim: To determine peak and average pressures achieved with PEP therapy in infants
with CF under the age of 3.
Methods: This study focused on infants (N = 9) with CF who use a PEP mask as
part of their normal routine. A digital manometer (Druck DPI 700) was attached to
a PEP mask via 80 cm of 02 tubing. Peak pressures were recorded every 2nd breath
for 10 breaths and an average pressure was then also calculated.
Results: Average pressure of 4.37 cmH20 with SD of 2.31 cmH20.
Conclusion: All average pressures achieved in this study were below the current
guidelines of 10−20 cmH20. Only 3 readings out of 45 hit this range. In our clinical
practice in infants we ﬁnd these parameters have a positive clinical effect. Longer-
term, higher-powered trials are indicated.
Reference(s)
Darbee, J.C et al (2004) Physiologic evidence for the efﬁcacy of positive expiratory
pressure as an airway clearance technique in patients with cystic ﬁbrosis. Phys
Ther. 84: 524–537.
Elkins M et al (2006) Positive expiratory pressure physiotherapy for airway clearance
in people with cystic ﬁbrosis. Cochrane Database of Systematic Reviews Issue 2.
214 Individual efﬁcacy of Cough Technique versus Forced Expiration
Technique in cystic ﬁbrosis
S. Gursli1, L. Sandvik2, B. Skrede1, B. Stuge3. 1Oslo University Hospital, Ulleval,
Norwegian Resource Centre for Cystic Fibrosis, Oslo, Norway; 2Oslo University
Hospital, Ulleval, Dept of Biostatistics, Epidemiology and Health Economics,
Oslo, Norway; 3Oslo University Hospital, Ulleval, Dept of Ortopaedics, Oslo,
Norway
Background: Physiotherapy for airway clearance is recommended in cystic ﬁbrosis,
but limited evidence exists to suggest that one technique or approach is better
than another. Removal of bronchial secretions is essential, and Forced Expiration
Technique (FET) is commonly used, though a new Cough Technique (CT) might
represent an alternative.
Objectives: To compare short-term efﬁcacy of CT versus FET on sputum expec-
toration and to investigate patient’s preferences.
Methods: Randomized controlled individual trials in six patients were conducted.
Each trial included 8 weeks of treatment periods with two interventions each week,
one with CT and one with FET. Primary outcome measure was sputum wet weight
(g). Secondary outcomes were self-reported preference and perceived utility value.
Additional measurements included oxygen saturation, heart rate and lung function.
Results: Most patients removed more sputum with CT than with FET. Sputum
weight favoured CT in 8 of 8 possible weeks in three patients (p = 0.008), in 7 of
8 weeks in one patient (p = 0.062), and in 6 of 8 weeks in one patient (p = 0.296).
FET was the most effective in one patient in 7 of 8 weeks (p = 0.062). In the
patients with signiﬁcantly higher mean sputum weight when using CT, differences
were 21%, 39% and 23% respectively. Patients reported both techniques as effective,
easy to understand and to perform, CT being associated with greater ease to use
and normalizing in everyday life. Three patients preferred CT, one FET, and two
had no preference.
Conclusion: CT appears to be effective, safe, and preferred in most patients, thus
providing a promising alternative to FET in daily treatments.
215 Comparison of acute effects of conventional high frequency
chest oscillation (HFCWO) and hand held percussor (Electro-Flo
5000) for airway clearance in cystic ﬁbrosis patients
C. Dunn1, Z. Davies1, L. Kim1, J. Zirbes1, C. Everson1, C. Milla1. 1Stanford
University, Palo Alto, United States
Objectives: An arsenal of treatment options for airway clearance is available to
CF patients. We proposed that a small hand held percussor (Electro-Flo 5000, EF)
with postural drainage would provide as much beneﬁt in mucous clearance as that
obtained with the high frequency chest wall oscillation Vest (HFCWO).
Methods: This was a randomized, cross over study in which ﬁfteen CF patients
(13−53 years of age) with daily sputum production were enrolled. Participants
were randomized to a therapy session with either EF or HFCWO. Participants
were required to come to clinic in the morning for two separate study visits, one
day apart. Therapy was provided by a registered respiratory therapist proﬁcient in
both modalities. The primary outcome was sputum production. During the therapy
session any sputum produced was collected in a pre-weighed cup. Sputum was
weighed immediately and was then placed without a lid into a 150ºC oven for
72 hours to measure the sputum solids dry weight. Secondary measures included
changes in respiratory rate, pulse oximetry, and pulmonary function as a result of
each therapy session.
Results: The therapy sessions with both devices were well tolerated. No difference
in sputum production, being it wet (4.6 g ±3.8 EF vs. 4.13 g ±2.7 HFCWO) or
dry (0.18±0.25 g EF vs. 0.15±0.16 g HFCWO) weights, was noted between the
treatments (p> 0.2 for comparisons). Only small, non-signiﬁcant changes were
noted in all secondary outcomes between treatment groups.
Conclusion: Both therapeutic modalities were comparable in their efﬁcacy in
promoting sputum mobilization. No signiﬁcant effects in other clinical parameters
were noted.
216 Periodic application of continuous positive airway pressure
(pCPAP) as airway clearance technique during advanced lung
disease in cystic ﬁbrosis: Another clue?
S. Gambazza1, S. Zuffo2, D. Innocenti2, R. Pasotto3, E. Mariotti2, M. Masolini2,
C. Braggion3. 1Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico,
Cystic Fibrosis Centre, Milano, Italy; 2AOU Meyer, Rehabilitation Unit, Florence,
Italy; 3AOU Meyer, Cystic Fibrosis Centre, Florence, Italy
Background: Literature conﬁrms that there is little evidence to support the use
of one airway clearance technique over another. Patients’ preference continues to
be the factor when dealing with respiratory physiotherapy (RP). In our practice
replacement of the widely accepted PEP-Mask with pCPAP is suspected to occur
when there is a repeated subjective worsening of respiratory conditions.
Aim: To show any evidence that pCPAP comes when clinical picture worsen; to
investigate any relationship between pCPAP beginning and non-invasive ventilation
initiation (NIV).
Methods: We revised 283 clinical records of patients regularly followed in 2010.
Descriptive analysis and contingency tables were performed together with Wilcoxon
signed rank test with signiﬁcance set at 5%.
Results: 20 patients substituted the usual PEP-Mask with pCPAP. It was started
at 24.7 mean age (sd 10.9, min 3.6-max 40). 88.6% had a Fev1 <40 and 53.3%
was underweight. 40% of patients was chronically colonized with Pseudomonas
aeruginosa and 52.9% did more than 4 i.v. treatment/year. 50% was already on
oxygen therapy and only 10% was on NIV at night. pCPAP was initiated because
of desaturation during PEP-Mask (50%), global fatigue (35%) and dyspnoea (15%)
during physiotherapy. A signiﬁcant association between oxygen therapy and i.v.
therapies was found (p = 0.002) and pCPAP was initiated signﬁcantly in advance
(p = 0.01) compared to NIV.
Conclusions: Respiratory physiotherapy carried out using pCPAP occurs signiﬁ-
cantly before the introduction of NIV and in advanced lung disease. As a “bridge
to bridge”, pCPAP might sustain airway clearance sessions and relief symptoms.
